Javelin Minerals: Following in the golden footsteps of Spectrum and Spartan?

Listen to ASX-listed Javelin Minerals Executive Chairman Brett Mitchell talk to Matt Birney on the Bulls N’ Bears Report about Javelin’s plan to emulate the spectacular successes of Spectrum Metals and Spartan Resources, both of which found multimillion-dollar gold deposits near old historic open pits.

See omnystudio.com/listener for privacy information.

Dateline Resources: Barrick gave up this gold project and now it will make $47m a year!

Listen to ASX-listed Dateline Resources Managing Director Steve Baghdadi talk to Matt Birney on the Bulls N’ Bears Report about Dateline’s scoping study on a project in the USA it snatched from Barrick Gold 3 years ago, that will churn out 75,000 ounces of gold a year for at least 8 years.

See omnystudio.com/listener for privacy information.

Lithium Australia: Sure beats mining it – sucking millions in lithium and nickel out of old lithium batteries

Listen to ASX-listed Lithium Australia Managing Director Simon Linge talk to Matt Birney on the Bulls N’ Bears Report about Lithium Australia’s lithium battery recycling division that has hit its straps with a record quarterly profit derived from sucking lithium and nickel out of old lithium batteries.

See omnystudio.com/listener for privacy information.

Kali Metals: Why are mega-miners like Min Res and SQM hanging around this ASX junior?

Listen to ASX-listed Kali Metals Managing Director Paul Adams talk to Matt Birney on the Bulls N’ Bears Report about Kali’s multimillion-dollar WA farm in deal with one of the biggest lithium miners on the planet.

See omnystudio.com/listener for privacy information.

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete response in one patient and lots with a 90 per cent plus reduction in signs of prostate cancer using “copper” based radiopharmaceuticals.

See omnystudio.com/listener for privacy information.

Xanadu Mines: A copper/gold PFS with biblical scale numbers!

Listen to ASX-listed Xanadu Mines Executive Chairman Colin Moorhead talk to Matt Birney on the Bulls N’ Bears Report about Xanadu’s crazy big pre-feasibility study numbers on its massive copper-gold play that has enough mineralisation to be mined for three decades.

See omnystudio.com/listener for privacy information.

Chariot Corporation: A new scalable lithium mining strategy and a doubled share price!

Listen to ASX-listed Chariot Corporation Managing Director Shanthar Pathmanathan talk to Matt Birney on the Bulls N’ Bears Report about Chariot’s new plan to just build a small-scale lithium mine that can be ramped up quickly when the lithium market takes off again.

See omnystudio.com/listener for privacy information.

Amplia Therapeutics: An oral cancer drug trial with serious results!

Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein.

See omnystudio.com/listener for privacy information.